Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Anchorage Capital Group, L.L.C. (CIK 1300714) reported $450.5M across 3 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: EQPT ($349.4M, 77.56%), S ($83.8M, 18.60%), DNA ($17.3M, 3.84%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | EQPT | EQUIPMENTSHARE COM INC | $349.4M | 77.56% | 17.8M | Hold |
| 2 | S | SENTINELONE INC | $83.8M | 18.60% | 4.9M | Hold |
| 3 | DNA | GINKGO BIOWORKS HOLDINGS INC | $17.3M | 3.84% | 1.7M | Hold |
Source: SEC Form 13F filings · as of 2026-06-30